BPO has made significant progress since listing which is not reflected in the current price, fair value is 13 cents. Price pressure is likely to remain until the capital raising is finalized in mid October. 20 Mil new shares will be issued @ a 15% discount to the weighted avg market price over the last 5 trading days which starts from tomorrow. Good news results in massive spikes. Sumitomo and Newfarm are conducting field trials of Qcide, and will compete for the exclusive license. Bioprospect has struck GOLD with a revolutionary insecticide called Qcide, a novel pesticide coded AP778, a neutraceutical called PC-Oz, as well as a valuable library of natural extracts that will be licensed to the R&D departments of its customers. BPO has many other revolutionary discoveries under the belt. Take a close look for the good investment @ current price.
E-mail: [email protected]
- Forums
- ASX - By Stock
- BPO
- EXCITING INVESTMENT
EXCITING INVESTMENT
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BPO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online